News

Filter

Current filters:

Reproductive

51 to 60 of 96283 results

Adaptimmune completes $104 million round of financing to advance cancer therapies

Adaptimmune completes $104 million round of financing to advance cancer therapies

25-09-2014

Adaptimmune, a UK biotech company focused on using T-cell therapy to treat cancer and infectious disease,…

AdaptimmuneBiotechnologyFinancialGlaxoSmithKlineOncologyUK

Helsinn to present anamorelin Phase III data at European Society for Medical Oncology Congress

Helsinn to present anamorelin Phase III data at European Society for Medical Oncology Congress

25-09-2014

Family-run Swiss oncology specialist Helsinn is to present Phase III data on anamorelin at the 38th European…

anamorelinHelsinnOncologyPharmaceuticalResearchSwitzerland

GlaxoSmithKline confirms Sir Philip Hampton to be chairman

GlaxoSmithKline confirms Sir Philip Hampton to be chairman

25-09-2014

UK pharma giant GlaxoSmithKline this morning confirmed recent rumors, saying that Sir Philip Hampton…

BoardroomGlaxoSmithKlineManagementPharmaceuticalUKUnited Kingdom

Shire to pay $56.5 million in final agreement with US government

Shire to pay $56.5 million in final agreement with US government

25-09-2014

The US subsidiary of Ireland-headquartered Shire will pay $56.5 million to resolve civil allegations…

AbbVieAdderallFinancialLegalPharmaceuticalShireUSAVyvanse

Baxter and Merrimack enter exclusive licensing agreement for MM-398 compound outside the USA

Baxter and Merrimack enter exclusive licensing agreement for MM-398 compound outside the USA

24-09-2014

Baxter International and oncology specialist Merrimack have launched a collaboration to develop and commercialize…

Baxter InternationalBiotechnologyLicensingMerrimackMM-398OncologyUSA

Acorda Therapeutics to acquire Civitas for $525 million

24-09-2014

US biotech firm Acorda Therapeutics has entered into an agreement to acquire Civitas Therapeutics, a…

Acorda TherapeuticsBiotechnologyCivitas TherapeuticsCVT-301Mergers & AcquisitionsNeurological

Gilead files for Japanese approval of ledipasvir/sofosbuvir for hepatitis C

24-09-2014

Gilead Sciences has submitted a New Drug Application to Japan’s Pharmaceutical and Medical Devices…

Anti-viralsBiotechnologyGilead SciencesJapanledipasvirRegulationsofosbuvir

51 to 60 of 96283 results

Back to top